Treatment Innovations
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center.
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial.
Phase II Study Explores Chemo-Free Regimen for HER2-Altered … : Oncology Times
A recent Phase II study has explored the potential of a chemotherapy-free regimen for treating certain cancer patients, offering a promising alternative to traditional chemo-based therapies
Researchers find a way to stop harmful cells after cancer treatment
Researchers from the University of Barcelona describe a mechanism for eliminating harmful cells from cancer treatment
Safdarjung Hospital offers CAR-T cell therapy
Delhi’s Safdarjung Hospital has successfully treated a patient with refractory Non-Hodgkin lymphoma using Chimeric Antigen Receptor T-cell (CAR-T) therapy. With this, Safdarjung has become India’s first hospital to provide the advanced immunotherapy. It has also set a new standard for cancer care in public hospitals. CAR-T cell therapy, an innovative form of treatment, harnesses the […]
Breast cancer: Three times I learnt my diet was wrong – and how to avoid my mistakes
A breast cancer survivor shares her experiences with dietary mistakes during treatment and offers advice on proper nutrition.
Cancer protein discovery reveals new treatment target
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not only improves our understanding of why this type of cancer can be aggressive in some people, but it also highlights a potential treatment target.
Cancer vaccine being created by scientists could stop disease up to 20 years early
A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop
Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer
Add-on camrelizumab-rivoceranib also trended toward better OS in CARES-005
Breast cancer cure rates almost doubled in combo therapy trial
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost doubled – the cure rate for patients with the most common kind of breast cancer. The findings suggest adopting a new treatment paradigm for the disease.
Leap Therapeutics stock tumbles after mid-stage trial setback
Leap Therapeutics (LPTX) shares fell after the company announced a setback in its mid-stage clinical trial for a cancer treatment.
Aromatic plant can fight colorectal cancer, say scientists
Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ability to treat colorectal cancer.
Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) into the T-cells meant to attack it.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
Three-fourths of patients had clear margins after surgery
Neoadjuvant Chemoradiation Plus Immunotherapy Boosts Responses in Esophageal Cancer
Phase III trial suggests regimen ‘has the potential to become the new standard of care’
Bristol Myers’ colorectal cancer drug significantly reduces relapse risk
Clinical trials indicate that Bristol Myers’ new drug effectively lowers the risk of cancer relapse in colorectal patients.
asy Breakfast Ideas That May Lower Your Cancer Risk
Discover simple and nutritious breakfast recipes that could help reduce the risk of cancer, according to nutrition experts.
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
FRIDAY, Jan. 24, 2025 (HealthDay News) — Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr
Tracking periods could save your life, doctor warns
<span id="docs-internal-guid-81c4d712-7fff-cf68-1169-5eeab0899cbc">One of the most common cancers, particularly in young people, could be overlooked in its early stages</span>
Prostate cancer and AI: The exciting advances that could transform treatment
Exploring how artificial intelligence is revolutionizing prostate cancer treatment, from early detection to personalized therapy plans.
Cancer breakthrough: New jab could slash risk of cervical cancer
More than half of those given a new vaccine in a clinical trial saw their pre-cancerous cells destroyed
Video games could accelerate discoveries in cancer research
Cancer research is complex, but video games can help. Jeff Yoshimi believes gamers can contribute to scientific breakthroughs.
Study shows a key to longer survival for cancer patients
a key to longer survival for cancer patients
Chinese team says vaccine shows promise in treating breast cancer in mice
Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.
